The Efficacy of Insulin Degludec/Liraglutide in Controlling Glycaemia in Adults With Type 2 Diabetes Inadequately Controlled on GLP-1 Receptor Agonist and OAD Therapy (opens ClinicalTrials.gov)
- Sponsor
- Novo Nordisk A/S
- Enrolment
- 438
- Started
- 2012-08-29
- Last update
- 2019-01-03
Conditions: Diabetes, Diabetes Mellitus, Type 2
Interventions: insulin degludec/liraglutide, liraglutide, exenatide